Endo International (ENDP) Competitors

Calithera Biosciences (NASDAQ:CALA) and Endo International (NASDAQ:ENDP) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, valuation, community ranking, dividends, institutional ownership, profitability, analyst recommendations, earnings and risk.

Which has stronger valuation & earnings, CALA or ENDP?

Calithera Biosciences has higher earnings, but lower revenue than Endo International.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Calithera Biosciences	$9.75M	0.01	-$39.65M	N/A	N/A
Endo International	$2.99B	0.00	-$613.24M	-$11.07	N/A

Is CALA or ENDP more profitable?

Calithera Biosciences has a net margin of 0.00% compared to Calithera Biosciences' net margin of -93.31%. Endo International's return on equity of 0.00% beat Calithera Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Calithera Biosciences	N/A	N/A	N/A
Endo International	-93.31%	-34.25%	6.72%

Does the media refer more to CALA or ENDP?

In the previous week, Endo International had 2 more articles in the media than Calithera Biosciences. MarketBeat recorded 3 mentions for Endo International and 1 mentions for Calithera Biosciences. Calithera Biosciences' average media sentiment score of 0.01 beat Endo International's score of 0.00 indicating that Endo International is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Calithera Biosciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Endo International	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Does the MarketBeat Community prefer CALA or ENDP?

Endo International received 580 more outperform votes than Calithera Biosciences when rated by MarketBeat users. Likewise, 63.69% of users gave Endo International an outperform vote while only 59.72% of users gave Calithera Biosciences an outperform vote.

Company	Underperform	Outperform
Calithera Biosciences	Outperform Votes 341 59.72%	Underperform Votes 230 40.28%
Endo International	Outperform Votes 921 63.69%	Underperform Votes 525 36.31%

Do institutionals and insiders hold more shares of CALA or ENDP?

80.4% of Endo International shares are owned by institutional investors. 6.6% of Calithera Biosciences shares are owned by company insiders. Comparatively, 1.2% of Endo International shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Do analysts rate CALA or ENDP?

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Calithera Biosciences	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
Endo International	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Summary

Endo International beats Calithera Biosciences on 7 of the 11 factors compared between the two stocks.